Showing results (101-110 of 121) with videos related to
Sort By:
Pageof 13
Kidney International|December 21, 2024
The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trialBalazs Odler, Regina Riedl, Duvuru Geetha, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 10, 2023
Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendationsMarta Casal Moura, Philipp Gauckler, Hans-Joachim Anders, et al.Journal of the American Society of Nephrology : JASN|November 29, 2022
Risk Stratification to Predict Renal Survival in Anti-Glomerular Basement Membrane DiseaseLauren Floyd, Sebastian Bate, Abdul Hadi Kafagi, et al.Frontiers in Immunology|September 28, 2023
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseasesPhilipp Gauckler, Jana S Kesenheimer, Duvuru Geetha, et al.Journal of the American Society of Nephrology : JASN|November 9, 2014
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvementDuvuru Geetha, Ulrich Specks, John H Stone, et al.Nature Reviews. Rheumatology|October 16, 2025
Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitisMarta Casal Moura, Peter A Merkel, David Jayne, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2024
Proteinuria as an End Point in Clinical Trials of Focal Segmental GlomerulosclerosisLaura H Mariani, Howard Trachtman, Aliza Thompson, et al.American Journal of Nephrology|September 8, 2017
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated GlomerulonephritisDuvuru Geetha, Sanjeev Sethi, An S De Vriese, et al.Annals of the Rheumatic Diseases|August 16, 2022
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remissionGabriele Gamerith, Finn Mildner, Peter A Merkel, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 4, 2022
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVASKate I Stevens, Eleni Frangou, Jae I L Shin, et al.Pageof 13